Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Samii

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Annals of Neurology|May 22, 2007
Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's diseaseCyrus P Zabetian, Carolyn M Hutter, Stewart A Factor, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 12, 2008
Genetic association between alpha-synuclein and idiopathic Parkinson's diseaseDenise M Kay, Stewart A Factor, Ali Samii, et al.
European Journal of Neurology|December 21, 2007
Lack of evidence for an association between UCHL1 S18Y and Parkinson's diseaseCarolyn M Hutter, Ali Samii, Stewart A Factor, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 18, 2014
Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotypeChristine R Swanson, Katherine Li, Travis L Unger, et al.
American Journal of Human Genetics|September 9, 2006
LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia agoCyrus P Zabetian, Carolyn M Hutter, Dora Yearout, et al.
Nature Genetics|August 17, 2010
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's diseaseTaye H Hamza, Cyrus P Zabetian, Albert Tenesa, et al.
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disordersFadi Abdi, Joseph F Quinn, Joseph Jankovic, et al.
JAMA|January 8, 2009
Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trialFrances M Weaver, Kenneth Follett, Matthew Stern, et al.
Archives of Neurology|November 10, 2010
SNCA variant associated with Parkinson disease and plasma alpha-synuclein levelIgnacio F Mata, Min Shi, Pinky Agarwal, et al.
The New England Journal of Medicine|June 4, 2010
Pallidal versus subthalamic deep-brain stimulation for Parkinson's diseaseKenneth A Follett, Frances M Weaver, Matthew Stern, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Annals of Neurology|May 22, 2007
Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's diseaseCyrus P Zabetian, Carolyn M Hutter, Stewart A Factor, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 12, 2008
Genetic association between alpha-synuclein and idiopathic Parkinson's diseaseDenise M Kay, Stewart A Factor, Ali Samii, et al.
European Journal of Neurology|December 21, 2007
Lack of evidence for an association between UCHL1 S18Y and Parkinson's diseaseCarolyn M Hutter, Ali Samii, Stewart A Factor, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 18, 2014
Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotypeChristine R Swanson, Katherine Li, Travis L Unger, et al.
American Journal of Human Genetics|September 9, 2006
LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia agoCyrus P Zabetian, Carolyn M Hutter, Dora Yearout, et al.
Nature Genetics|August 17, 2010
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's diseaseTaye H Hamza, Cyrus P Zabetian, Albert Tenesa, et al.
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disordersFadi Abdi, Joseph F Quinn, Joseph Jankovic, et al.
JAMA|January 8, 2009
Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trialFrances M Weaver, Kenneth Follett, Matthew Stern, et al.
Archives of Neurology|November 10, 2010
SNCA variant associated with Parkinson disease and plasma alpha-synuclein levelIgnacio F Mata, Min Shi, Pinky Agarwal, et al.
The New England Journal of Medicine|June 4, 2010
Pallidal versus subthalamic deep-brain stimulation for Parkinson's diseaseKenneth A Follett, Frances M Weaver, Matthew Stern, et al.
Pageof 9